Filter
1463
Filtered Results: 1463
Text search:
diagnóstico
molecular
Featured
Recommendations
170
New Publications
274
Language
Document type
No document type
661
Guidelines
342
Studies & Reports
233
Manuals
82
Strategic & Response Plan
73
Fact sheets
39
Training Material
12
Situation Updates
12
Resource Platforms
6
Infographics
2
Brochures
1
Countries / Regions
India
78
Latin America and the Carribbean
63
Western and Central Europe
53
Brazil
51
Global
44
Africa
35
Eastern Europe
35
Colombia
29
Kenya
25
South Africa
21
Peru
21
Ethiopia
19
Tanzania
18
Argentina
18
West and Central Africa
17
El Salvador
16
Venezuela
16
Russia
16
Germany
15
East and Southern Africa
15
Paraguay
14
Mozambique
13
Senegal
11
Uganda
11
Malawi
11
Sierra Leone
10
Nigeria
10
Bolivia
10
Chile
10
South–East Asia Region
10
Asia
10
Philippines
9
Zambia
9
Ecuador
9
Angola
9
Liberia
8
Rwanda
8
Ukraine
8
Bangladesh
7
Ghana
6
Middle East and North Africa
6
Congo, Democratic Republic of
5
Zimbabwe
5
Nepal
5
Namibia
5
Eastern Europe and Central Asia
5
Spain
5
USA
4
Cameroon
4
Indonesia
4
Myanmar / Burma
4
Western Pacific Region
4
Guinea
3
Burkina Faso
3
Haiti
3
Pakistan
3
Benin
3
Eswatini/ Swaziland
3
Uruguay
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Syria
2
Cambodia
2
Dominican Republic
2
Honduras
2
Guatemala
2
Georgia
2
North America
2
Mali
1
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Jordan
1
Turkey
1
Chad
1
Thailand
1
Gambia
1
China
1
Mauritania
1
Cuba
1
Botswana
1
Libya
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Italy
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Romania
1
Turkmenistan
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
194
Pharmacy & Technologies
60
Public Health
53
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
TB
367
COVID-19
230
AMR
94
NTDs
90
HIV
75
Rapid Response
66
Mental Health
60
Ebola
34
Zika
28
Planetary Health
25
Pharmacy
23
NCDs
16
Polio
12
Refugee
12
Caregiver
9
Cholera
8
Global Health Education
6
Specific Hazards
5
Disability
4
Natural Hazards
4
Health Financing Toolbox
4
Conflict
3
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон,
принимающих участие в диагностической работе для выявлен...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity for Surveillance and Response Program
orientaciones provisionales, 8 de noviembre de 2020
This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e...
To guide One Health capacity building efforts in the Republic of Guinea in the wake of the 2014–2016 Ebola virus disease (EVD) outbreak, we sought to identify and assess the existing systems and structures for zoonotic disease detection and control. We partnered with the government ministries resp...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ...
Clinical Microbiology and Infection Volume 21, Issue 5, May 2015, Pages 433-443;
The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries, but remain major causes of ill-health and mortality across Africa, Asia, and Latin America. This neglect is, in part, a conse...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
